10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from [                             ] to [                             ]

Commission file number 333-177463

AudioEye, Inc.

(Exact name of registrant as specified in its charter)

Delaware	20-2939845
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
5210 East Williams Circle, Suite 750, Tucson, Arizona	85711
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:  866-331-5324

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the last 90 days. Yes x     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x     No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Accelerated filer o
Non-accelerated filer o	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No x

As of May 13, 2016, 105,352,576 shares of the registrant’s common stock were issued and outstanding.

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015 (unaudited)	2
	Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015 (unaudited)	3
	Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015 (unaudited)	4
	Notes to Consolidated Financial Statements (unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19
Item 4.	Controls and Procedures	19
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	20
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Mine Safety Disclosures	20
Item 5.	Other Information	20
Item 6.	Exhibits	21
SIGNATURES		22

PART I — FINANCIAL INFORMATION

Item 1.  Financial Statements

The financial information set forth below with respect to the financial statements as of March 31, 2016 and 2015 and for the three month periods ended March 31, 2016 and 2015 is unaudited. This financial information, in the opinion of our management, includes all adjustments consisting of normal recurring entries necessary for the fair presentation of such data. The results of operations for the three month period ended March 31, 2016 are not necessarily indicative of results to be expected for any subsequent period. Our fiscal year end is December 31.

1 

AUDIOEYE, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

	March 31,			December 31,
	2016			2015
ASSETS
Current assets:
Cash	$	1,080,490		$	1,687,257
Accounts receivable, net		19,282			22,741
Marketable securities, held in related party		3,600			3,600
Non-marketable securities, held in related party		50,000			50,000
Prepaid expenses and other current assets		41,388			41,388
Total current assets		1,194,760			1,804,986
Intangible assets, net		2,738,385			2,840,856
Goodwill		700,528			700,528
Total assets	$	4,633,673		$	5,346,370
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities:
Accounts payable and accrued expenses	$	272,079		$	213,620
Notes and loans payable, current		24,000			24,000
Related party payables		135,710			153,474
Derivative liabilities		3,851,420			439,361
Deferred revenue		150,296			60,790
Total current liabilities		4,433,505			891,245
Long term liabilities:
Convertible notes and loans payable, net		1,963,640			1,923,499
Total liabilities		6,397,145			2,814,744
Stockholders' equity (deficit):
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, 175,000 issued and outstanding as of March 31, 2016 and December 31, 2015		2			2
Common stock, $0.00001 par value, 250,000,000 shares authorized, 81,717,154 shares issued and outstanding as of March 31, 2016 and December 31, 2015		817			817
Treasury stock		(623,000	)		(623,000	)
Additional paid in capital		27,609,016			27,393,238
Accumulated deficit		(28,750,307	)		(24,239,431	)
Total stockholders' equity (deficit)		(1,763,472	)		2,531,626
Total liabilities and stockholders' equity (deficit)	$	4,633,673		$	5,346,370

See Notes to Unaudited Consolidated Financial Statements

2 

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three months ended March 31,
	2016			2015
Revenues	$	124,702		$	101,038
Cost of revenue		294,808			462,131
Gross loss		(170,106	)		(361,093	)
Operating expenses:
Selling and marketing		123,366			366,368
Research and development		85,617			142,282
General and administrative		471,025			2,021,226
Amortization and depreciation		138,538			133,944
Total operating expenses		818,546			2,663,820
Operating loss		(988,652	)		(3,024,913	)
Other income (expense):
Unrealized loss on derivative liabilities		(3,412,059	)		-
Interest income (expense), net		(110,165	)		3,107
Total other income (expense)		(3,522,224	)		3,107
Net loss		(4,510,876	)		(3,021,806	)
Preferred stock dividend		(21,875	)		-
Net loss available to common stockholders	$	(4,532,751	)	$	(3,021,806	)
Net loss per common share-basic and diluted	$	(0.06	)	$	(0.04	)
Weighted average common shares outstanding-basic and diluted		81,717,154			78,736,420

See Notes to Unaudited Consolidated Financial Statements

3 

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three months ended March 31,
	2016			2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(4,510,876	)	$	(3,021,806	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		138,538			133,944
Amortization of debt discounts		46,141			-
Option, warrant and PSU expense		215,778			559,793
Stock issued for services		-			314,663
Loss on change in derivative liabilities		3,412,059			-
Changes in operating assets and liabilities:
Accounts receivable		3,459			237,758
Other current assets		-			(48,713	)
Accounts payable and accruals		58,459			(274,164	)
Related party payables		(17,764	)		(91,408	)
Deferred revenue		89,506			(228,983	)
Net cash (used in) operating activities		(564,700	)		(2,418,916	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash (paid for) intellectual property		(36,067	)		(29,650	)
Net cash (used in) investing activities		(36,067	)		(29,650	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock for cash		-			325,000
Collection of stock subscription receivable		-			1,175,000
Proceeds from exercise of options and warrants		-			43,942
Repayments of notes payable		(6,000	)		(8,000	)
Net cash (used in) provided by financing activities		(6,000	)		1,535,942
Net decrease in cash		(606,767	)		(912,624	)
Cash-beginning of period		1,687,257			1,672,901
Cash-end of period	$	1,080,490		$	760,277
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	-		$	307
Income taxes paid	$	-		$	-

See Notes to Unaudited Consolidated Financial Statements

4 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION

The accompanying unaudited interim financial statements of AudioEye, Inc. and its wholly-owned subsidiary (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2016.

In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2015 as reported in the Company’s Annual Report on Form 10-K have been omitted.

Corporate Information and Background

AudioEye, Inc. was formed as a Delaware corporation on May 20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company’s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company’s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation.

Revenue Recognition

Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract.

The Company had three major customers including their affiliates which generated approximately 72% (43%, 16% and 13%) of its revenue in the three months ended March 31, 2016.

Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue is earned.

5 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.

Stock based compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.

Derivative Instrument Liability

The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At March 31, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.

On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to $25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In accordance with ASC 815, the outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At March 31, 2016 and December 31, 2015, the derivative liability was stated at $3,851,420 and $439,361, respectively. The change of $3,412,059 was driven by the increased value of the Company’s common stock in the period and recorded as the “Loss on change in derivative liability” in the Consolidated Statements of Operations. As the warrants are exercised or expire, the derivative liability will be reduced on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.

Fair Value Measurements

Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels: 

6 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value. The notes are not yet convertible, but the notes with any accrued interest automatically convert on the event of an equity capital raise of at least $2.0 million.

The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years. At March 31, 2016, the price of the Company stock was 0.161, volatility was estimated to be 178.22%, the risk free rate of 1.21% and the remaining term ranged from 4.53 to 4.61 years. As of March 31, 2016, the fair value of the warrants was determined to be $3,851,420, resulting in an unrealized loss on the change in the fair value of this derivative liability of $3,412,059 for the three months ended March 31, 2016.

The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of March 31, 2016 and December 31, 2015:

			Fair Value
	Fair Value		Hierarchy
Assets
Marketable securities, March 31, 2016	$	3,600		Level 1
Marketable securities, December 31, 2015	$	3,600		Level 1
Liabilities
Derivative Liability , March 31, 2016	$	3,851,420		Level 3
Derivative Liability , December 31, 2015	$	439,361		Level 3

7 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

Recent Accounting Pronouncements

In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance.

There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

NOTE 2: MANAGEMENT LIQUIDITY PLANS

The accompanying unaudited financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which contemplates the continuation of the Company as a going concern. As of March 31, 2016, the Company had a working capital deficit of $3,238,745, principally due to the inclusion of non-cash derivative liability recorded in current liabilities. Excluding the derivative liability, the Company’s working capital would have been $612,675. In addition, the Company used actual net cash in operations of $564,700 during the three months ended March 31, 2016.

On April 18, 2016 (the “Initial Closing Date”) and subsequent to these financial statements, the Company entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors for the issuance and sale of up to 14,285,714 shares of common stock of the Company and warrants to purchase up to an aggregate of 1,600,000 shares of Common Stock, representing up to $2,000,000 of proceeds, in one or more closings within 30 days of the Initial Closing Date (the “Transaction”). The warrants are exercisable at $0.25 per share for five years from the date of issuance and subject to anti-dilution protection as defined. As of May 10, 2016, the Company has received proceeds, net of costs, of $1,500,000.

Management believes that the Company has sufficient funds to meet its operating funding requirements for at least the next twelve months. The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.

NOTE 3: RELATED PARTY TRANSACTIONS

The Company holds 60,000 shares in Peartrack Security Systems, formerly Ecologic Transportation, as of March 31, 2016 resulting from the conversion of a $60,000 accounts receivable balance in 2014 with a current fair value of the securities of $3,600. In 2014 the Company invested $50,000 in Cannonball Red in return for 97,500 shares held as of March 31, 2016. Both companies were affiliated with related parties who resigned from the Company during the quarter.

8 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors

As of March 31, 2016 and December 31, 2015, the Company owed Dr. Bettis $49,742 and $72,944 in accrued salary, respectively. In addition, AudioEye sub-leases an office for the Company’s CEO Todd Bankofier from Verus Analytics, Inc, a company in which Dr. Bettis has a controlling interest in. The sub-lease amount is $500 per month totaling $1,500 in three months ended March 31, 2016.

Sean Bradley, President, Chief Technology Officer, and Secretary

As of March 31, 2016 and December 31, 2015 and 2014, the Company owed Sean Bradley $9,794 and $6,250 in accrued salary, respectively.

David Moradi, a Material Shareholder, on a fully diluted basis

As of March 31, 2016 and December 31, 2015 the Company owed David Moradi $70,000 in principal and $6,174 in accrued interest; and $70,000 in principal and $4,280 in accrued interest, respectively.

In summary, as of March 31, 2016 and December 31, 2015 the total balances of related party payables were $135,710 and $153,474, respectively.

NOTE 4: INTANGIBLE ASSETS

For the three months ended March 31, 2016 and 2015, the Company invested in Patents in the amounts of $36,067 and $29,650 respectively.

Prior to December 31, 2015, patents, technology and other intangibles with contractual terms were generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.

Software development costs are amortized over their estimated useful life of three years.

Prior to any impairment adjustment, intangible assets consisted of the following:

	March 31,			December 31,
	2016			2015
Patents	$	3,691,136		$	3,655,069
Capitalized software development		621,567			621,567
Accumulated amortization		(1,574,318	)		(1,435,780	)
Intangible assets, net	$	2,738,385		$	2,840,856

Amortization expense for patents totaled $92,779 and $90,736 for the three months ended March 31, 2016 and 2015, respectively. Amortization expense for software development totaled $45,759 and $43,125 for the three months ended March 31, 2016 and 2015, respectively.

Total amortization expense totaled $138,538 and $133,944 for the three months ended March 31, 2016 and 2015, respectively.

NOTE 5: NOTES PAYABLE

As of March 31, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $1,963,640, and $24,000 and $1,923,499, respectively as shown in the table below.

9 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

Notes and loans payable	March 31, 2016		December 31, 2015
Short Term
Maryland TEDCO	$	24,000	$	24,000
Total	$	24,000	$	24,000
Long Term
Convertible Secured Note (net of unamortized discounts of $554,160 and $600,301, respectively)		1,945,840		1,899,699
Maryland TEDCO	$	17,800	$	23,800
Total	$	1,963,640	$	1,923,499

As of December 31, 2012, the Company had an outstanding loan to a third party in the amount of $74,900, which was originally issued during 2006 as part of an Investment Agreement. The loan was unsecured and bore interest at 25% per year for four years. The Company had accrued interest of $74,900, which was included in accounts payable and accrued expenses on the consolidated balance sheets.  The note was in default until October 24, 2011, at which time the Company entered into a Termination and Release Agreement (“Release”) with the third party.  The terms of the Release, among other things, terminated the Investment Agreement between the parties, and required the Company to issue a Promissory Note to the third-party in the combined amount of principal and accrued interest to date, for a total principal amount of $149,800.  The note is interest free, and is payable in monthly installments of $2,000 beginning November 1, 2011.  As of March 31, 2016 and December 31, 2015, the principal amount owing was $41,800 and $47,800, respectively, of which $24,000 and $24,000, respectively, has been recorded as the current portion of the note, and $17,800 and $23,800, respectively, as the long-term portion of the note. The Company has paid $6,000 for the three months ended March 31, 2016.

On October 9, 2015 (the “Initial Closing Date”), AudioEye, Inc. (the “Company”) entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) for the issuance and sale of convertible promissory notes in an aggregate principal amount of up to $3,750,000 (the “Notes”) and warrants (the “Warrants”) to purchase up to an aggregate of 37,500,000 shares of common stock of the Company (the “Common Stock”) (the “Transaction”). Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date. The maximum of $2,500,000 in aggregate principal was sold as of November 8, 2015. In addition, upon the election of any Investor within the three-year period immediately following the Initial Closing Date, any Investor may purchase an additional Note in the principal amount equal to 50% of the principal amount of the Notes purchased by such Investor at previous closings (the “Option Principal Amount”) and an additional Warrant with an aggregate exercise price equal to such Investor’s Option Principal Amount. The Notes mature three years from the date of issuance (the “Maturity Date”) and, until the Notes are repaid or converted into shares of the Company’s equity securities (“Equity Securities”), accrue payable-in-kind interest at the rate of 10% per annum.

If the Company sells Equity Securities in a single transaction or series of related transactions for cash of at least $2,000,000 (excluding the conversion of the Notes and excluding the shares of Common Stock to be issued upon exercise of the Warrants) on or before the Maturity Date (the “Equity Financing”), all of the unpaid principal on the Notes plus accrued interest shall be automatically converted at the closing of the Equity Financing into a number of shares of the same class or series of Equity Securities as are issued and sold by the Company in such Equity Financing (or a class or series of Equity Securities identical in all respects to and ranking pari passu with the class or series of Equity Securities issued and sold in such Equity Financing) as is determined by dividing (i) the principal and accrued and unpaid interest amount of the Notes by (ii) 60% of the price per share at which such Equity Securities are issued and sold in such Equity Financing. The Notes, if not converted, shall be due and payable in full on the Maturity Date.

10 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

The Notes contain customary events of default provisions. In connection with the issuance of the Notes, on October 9, 2015, the Company entered into a Security Agreement with the Investors (the “Security Agreement”) pursuant to which the Company granted a security interest in all of its assets to the Investors as collateral for the Company’s obligations under the Notes. The Warrants are exercisable at $0.10 per share and expire 60 months following the date of issuance. The Warrants are subject to anti-dilution protection, subject to certain customary exceptions.

During 2015, the Company issued notes under this offering totaling $2,500,000. The fair value of the warrants issued in connection with the notes was determined to be $627,293 and was recognized as a discount to the debt being amortized to interest expense over the life of the loans. During three months ended March 31, 2016, aggregate amortization of $46,141 was recognized against the discount.

NOTE 6: OPTIONS

As of March 31, 2016 and December 31, 2015, the Company has outstanding options to purchase 21,809,914 and 14,759,914 shares of common stock, respectively.

										Intrinsic
						Wtd Avg.				Value
	Number of			Wtd Avg.		Remaining				of Exercisable
	Options			Exercise Price		Term		Exercisable		Options
Outstanding at December 31, 2015		14,759,914		$	0.30		3.61		8,374,294	$	—
Granted		7,150,000			0.038		4.82				—
Forfeited		(100,000	)		0.50						—
Outstanding at March 31, 2016		21,809,914		$	0.22		3.78		10,313,220	$	383,168

On January 15, 2016, the Company granted performance options to acquire shares of the Company’s common stock in aggregate of 6,500,000 to key board member and officers at an exercise price of $0.038 per share for five years. Vesting shall only occur if the closing share price of the Company’s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition). Of the granted options, 5,500,000 include performance conditions (as defined) with both conditions (market and performance) to be met before vesting. All determinations of whether performance goals have been achieved, the number of vested performance options earned by the grantee, and all other matters related to the award of performance options shall be made by the compensation committee of the Company’s board of directors in its sole discretion.

The estimated fair values of the options with performance and market conditions were determined using a Monte Carlo pricing model. Significant assumptions used in the valuation include expected term of 5 years, expected volatility of 162%, risk free interest rate of 1.46%, and expected dividend yield of 0%.

Nonperformance option grants during the three months ended March 31, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.50 years, expected volatility of 102%, risk free interest rate of 1.73%, and expected dividend yield of 0%.

For the three months ended March 31, 2016 and 2015, total stock compensation expense related to the options totaled $138,046 and $505,052, respectively.

11 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

NOTE 7: WARRANTS

Below is a table summarizing the Company’s outstanding warrants as of March 31, 2016 and December 31, 2015:

									Intrinsic
					Wtd Avg.				Value
	Number of		Wtd Avg.		Remaining				of Exercisable
	Warrants		Exercise Price		Term		Exercisable		Warrants
Outstanding at December 31, 2015		42,526,609	$	0.22		4.15		41,047,920	$	1,167
Exercised		-
Granted		833,334		.06		3.07				-
Forfeited		-
Outstanding at March 31, 2016		43,359,943		0.21		3.87		43,141,193	$	1,666,625

The warrant grants during the three months ended March 31, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 2.5 years, expected volatility of 166.74% to 178.98%, risk free interest rate of 0.85% to 1.08%, and expected dividend yield of 0%.

For the three months ended March 31, 2016 and 2015, the Company has incurred warrant-based expense of $77,732 and $54,741, respectively. 

NOTE 8: SUBSEQUENT EVENTS

Equity

Common stock

In April 2016, the Company issued an aggregate 83,336 shares of its common stock in payment for consulting services at a fair value of $14,292.

In April 2016 (the “Initial Closing Date”) and subsequent to these financial statements, the Company entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors for the issuance and sale of up to 14,285,714 shares of common stock of the Company and warrants to purchase up to an aggregate of 1,600,000 shares of Common Stock, representing up to $2,000,000 of proceeds, in one or more closings within 30 days of the Initial Closing Date (the “Transaction”). The warrants are exercisable at $0.25 per share for five years from the date of issuance and subject to anti-dilution protection as defined. As of May 10, 2016, the Company has received proceeds, net of costs, of $1,500,000.

Registration rights

Under the purchase agreement, the Company has agreed to use its reasonable best efforts to prepare and file with the SEC registration statement within 60 days of the initial closing date, covering the resale by the investors of any common stock previously issued to the investors, and any common stock into which any convertible promissory notes previously issued to the investors are convertible and any common stock for which the warrants or any warrants previously issued to the investors are exercisable.

12 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2016 (Unaudited)

Amendments to Existing Agreements

In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Purchase Agreement Amendment”) and an Omnibus Amendment to Secured Promissory Notes (the “Note Amendment”), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the “Original Agreement”) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, “Anthion”) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of “qualified financing” under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing “blocker” provisions (“Special Warrants”) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar “blocker” provisions.

On April 18, 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to the Note holders other than Anthion, and 18,353,311 warrants to acquire its common stock to Anthion in lieu of common stock. Collectively the common stock and warrants issued were in full settlement of $2,500,000 convertible notes (Note 5) and accrued interest of $74,658. The warrants issued to Anthion are exercisable at $0.0005 per share for five years from the date of issuance.

Employee options/warrants

On April 15, 2016, the Company issued 347,995 warrants to Dr. Carr Bettis as compensation for services rendered. The warrants are exercisable at $0.0179 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on April 1, 2016.

On April 15, 2016, the Company granted 49,715 options to Sean Bradley as compensation for services rendered. The options are exercisable at $0.0179 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on April 1, 2016.

13 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations or MD&A, should be read in conjunction with our consolidated financial statements and related notes in Part I, Item 1 of this report.

As used in this quarterly report, the terms “we,” “us,” “our” and similar references refer to AudioEye, Inc. and our wholly-owned subsidiary, unless otherwise indicated.

Cautionary Note Regarding Forward-Looking Statements

Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, prospects, financial condition, assumptions or future events or performance are not historical facts and are “forward-looking statements” as that term is defined under the federal securities laws. These statements are often, but not always, made through the use of words or phrases such as “believe”, “anticipate”, “should”, “intend”, “plan”, “will”, “expects”, “estimates”, “projects”, “positioned”, “strategy”, “outlook” and similar words. You should read the statements that contain these types of words carefully. Such forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from what is expressed or implied in such forward-looking statements. There may be events in the future that we are not able to predict accurately or over which we have no control. Potential risks and uncertainties include, but are not limited to, those discussed in “Part I, Item 1A. Risk Factors” in our Annual Report filed on Form 10-K for the year ended December 31, 2015. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or uncertainties after the date hereof or to reflect the occurrence of unanticipated events.

Overview

AudioEye is a marketplace leader providing web accessibility solutions for our clients’ customers through our Ally Platform Products. Our technology advances accessibility with patented technology solutions that reduce barriers, expand access for individuals with disabilities, and enhance the user experience for a broader audience of users. When implemented, we believe that our solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty.  In addition, our solutions help organizations comply with internationally accepted Web Content Accessibility Guidelines (WCAG) as well as US, Canadian, Australian, and United Kingdom accessibility laws.

We generate revenues through the sale of subscriptions of our software as a service (SaaS) technology platform, called the AudioEye Ally Platform, to website owners, publishers, developers, and operators and through the delivery of managed services combined with the implementation of the AudioEye solution. Our solutions have been adopted by some of the largest and most influential companies in the world. Our customers span disparate industries and target market verticals, which encompass (but are not limited to) the following categories: human resources, finance, transportation, media, and education. Government agencies have also integrated our software in their digital platforms.

The AudioEye Solution

AudioEye uses proprietary technology and development tools to offer web accessibility solutions that offer significant savings in time and money relative to traditional solutions. Our compliance solutions focus on rapid remediation of the most important accessibility issues, followed by in-depth analysis identifying and addressing a more comprehensive compliance program. Our technology was built to not only provide users with a cloud-based assistive toolset that gets embedded and made freely available to users within our client websites, but to also improve the code in a way that optimizes the user experience for users of existing third-party assistive technologies, such as screen readers.

14 

Intellectual Property

Our technology development was initiated at the University of Arizona Science & Technology Park in Tucson, Arizona. In 2006, we received technology development venture funding from the Maryland Technology Development Corporation (TEDCO), which contributed to the development of our platform strategy. Beginning in 2009, we engaged in a multi-year technology development program with the Eller College of Management’s Department of Management Information Systems at the University of Arizona.  In connection with our proprietary technology, our company has been issued a number of U.S. patents in two distinct patent families.  Today, an experienced team of in-house engineers, designers, and developers in our Atlanta, GA, and Tucson, AZ, offices develop the Company’s technology & software and are actively engaged in the expansion of the AudioEye IP Portfolio.

Our patented technology was a 2013 Edison Gold Award winner for innovation in the category of “Quality of Life.”

Our intellectual property is primarily comprised of trade secrets, trademarks, issued and pending patents, copyrights and technological innovation. We have a patent portfolio comprised of six patents issued in the United States, we have received a notice of allowance from the U.S. Patent and Trademark Office for a seventh patent, and we have several additional patents that are either pending or are being prepared for filing in the United States and internationally.

Our current patented invention relates to a server-side method and apparatus that enables users to audibly navigate websites and hear high-quality streaming audio narration and descriptions of websites.  This patented invention involves creating an audio-enabled web experience by utilizing voice talent and automated text-to-speech conversion methods to read and describe web content. It involves the creation of audio files for each section within a website, and then assigning a hierarchy and navigation system in line with the website design.  To implement the system, a script is installed across the pages of the website and, when loaded, it plays an audible tone upon a user’s visit indicating that the website is enhanced with our proprietary technology.  Upon hearing the tone, a user presses a key on the keyboard to enter the audible website.  Audible narration is played through the user’s computer, reading text and describing non-text information, such as images.  The narration includes menus for navigating the site which have a hierarchy in line that of the original website.  Users navigate the website menus and move from webpage to webpage by making keystrokes or using a mouse.

Our current portfolio has established a foundation for building unique technology solutions that contribute to the way in which we differentiate ourselves from other competitors in the B2B Web Accessibility marketplace. We plan to continue to invest in research and development, and expand our portfolio of proprietary intellectual property.

Our Annual Report filed on Form 10-K for the year ended December 31, 2015 provides additional information about our business and operations.

Results of Operations

Our consolidated audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”). The discussion of the results of our operations compares the three months ended March 31, 2016 with the three months ended March 31, 2015 and are not necessarily indicative of the results which may be expected for any subsequent period.  Our prospects should be considered in light of the risks, expenses and difficulties encountered by companies in similar positions.  We may not be successful in addressing these risks and difficulties.

15 

Comparative for the Three Months ended March 31, 2016 and March 31, 2015

Results of Operations

	Three Months Ended
	March 31,
	2016			2015
Revenue		124,702		$	101,038
Cost of sales		294,808			462,131
Gross loss		(170,106	)		(361,093	)
Operating expenses:
Selling & marketing		123,366			366,368
Research & development		85,617			142,282
General and administrative expenses		471,025			2,021,226
Amortization & depreciation		138,538			133,944
Total operating expenses		(818,546	)		(2,663,820	)
Operating loss		(988,652	)		(3,024,913	)
Unrealized loss on derivative liabilities		(3,412,059	)		-
Interest income/(expense)		(110,165	)		3,107
Net (loss)	$	(4,510,876	)	$	(3,021,806	)
Deemed dividend on Series A Convertible preferred stock		(21,875	)		-
Net loss attributable to common stockholders		(4,532,751	)		(3,021,806	)
Net loss per common share – basic and diluted		(0.06	)		(0.04	)
Weighted average common shares outstanding – basic and diluted		81,717,154			78,736,420

Revenue

For the three months ended March 31, 2016 and 2015, revenue was $124,702 and $101,038, respectively, consisting primarily of revenues from various levels of licensing, website design and maintenance. Revenues increased due to a change of marketing focus.

Cost of Sales

For the three months ended March 31, 2016 and 2015, cost of sales was $294,808 and $462,131, respectively, consisting primarily of sub-contracting to outside sources, direct labor and direct technology costs.

Gross Loss

An increase in our implementation costs resulted in a gross loss of $170,106 and $361,093 during the three months ended March 31, 2016 and 2015, respectively. Gross loss decreased as a result of lower implementation costs as compared to the same period in 2015.

Selling and Marketing Expenses

Selling and marketing expenses were $123,366 and $366,368 for the three months ended March 31, 2016 and 2015, respectively.  The decrease resulted from the reduction primarily in staffing levels.

Research and Development Expenses

Research and development expenses were $85,617 and $142,282 for three months ended March 31, 2016 and 2015, respectively. Research and development expenses declined from period to period and reflect the material completion of our product.

16 

General and Administrative Expenses

General and administrative expenses were $471,025 and $2,021,226 for the three months ended March 31, 2016 and 2015, respectively. General and administrative expenses decreased as a result of employee staff reductions and the associated benefits costs as well as decrease in stock based compensation year over year.

Amortization and Depreciation

Amortization and depreciation expenses were $138,538 and $133,944 for the three months ended March 31, 2016 and 2015, respectively. The increase in expense was primarily related to added patent costs in later 2015 and 2016.

Loss on change in fair value of derivative liabilities

In 2015, we issued warrants with an embedded reset provisions requiring us to fair value the derivatives each reporting period and mark to market as a non-cash adjustment to our current period operations. This resulted in a loss of $3,412,059 on change in fair value of derivative liabilities for the three months ended March 31, 2016. None were issued as of March 31, 2015.

Interest Income (Expense), net

Interest income (expense), net during the three months ended March 31, 2016 was $(110,165) compared to $3,107 three months ended March 31, 2015. For 2016, Interest expense consists of amortization of debt discounts and interest incurred relating to our issued notes payable, as compared to interest income of $3,107 for the three months ended March 31, 2016

Contracts in Process/Revenue Recognition

Under current accounting procedures, the Company only recognizes revenue on new contracts for the actual services delivered in the period under the following criteria: i) the contract has been signed and delivered to the Company; ii) the services have been performed or delivered; and iii) the client has been billed for the services delivered. The Company does not record deferred revenues for new contracts until the first payment for services has been received. The Company only records accounts receivable for the amount of revenue recognized as service is rendered, even if the client has been billed for the entire contract value. The table below summarizes the amount of contract value in excess of the revenue recognized of $124,702 and the deferred revenue recognized of $150,296, in the amount of $515,596. This amount is expected to be recognized in future periods. The Company also receives contracts for service hours but whose total contract value is uncertain. These “fee for service contracts” are recorded in the table below only if the services have been delivered and the associated revenue has been recognized.

A summary of our contracts in process is as follows:

	Contracts in Process
	March 31, 2016
			Revenue		Revenue		Deferred		Contract Amount in Excess of Deferred
	Contract		Recognized		Recognized		Revenue		Revenue and
	Amount		prior to 2016		3 Months Ended March 31, 2016		March 31, 2016		Recognized Revenue
Fixed Contracts	$	779,645	$	50,889	$	62,865	$	150,296	$	515,595
Fee for Service Contracts		61,837				61,837
	$	841,482	$	50,889	$	124,702	$	150,296	$	515,595

17 

Liquidity and Capital Resources

Working Capital

	At March 31,			At December 31,
	2016			2015
Current Assets	$	1,194,760		$	1,804,986
Current Liabilities		4,433,505			891,245
Working Capital (Deficit)	$	(3,238,745	)	$	913,741

The working capital (deficit)/surplus for the periods ended March 31, 2016 and December 31, 2015 was $(3,238,745) and $913,741 respectively. The decrease in Working Capital was primarily due to an increase in our non-cash derivative liability and a decrease in Cash, net with an increase in accounts payables and accrued expenses. Adjusting for the non-cash derivative liability, Working Capital would have been $612,675 at March 31, 2016.

Management believes that the Company has sufficient funds to meet its operation funding requirements for at least the next twelve months. The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.

Cash Flows

	For the three months ended
	March 31,
	2016			2015
Net Cash (Used in) Operating Activities	$	(564,700	)	$	(2,418,916	)
Net Cash (Used in) Investing Activities		(36,067	)		(29,650	)
Net Cash (Used in) Provided by Financing Activities		(6,000	)		1,535,942
Decrease in Cash	$	(606,767	)	$	(912,624	)

We had cash in the amount of $1,080,490 and $1,687,257 as of March 31, 2016 and December 31, 2015, respectively.

On April 18, 2016 (the “Initial Closing Date”) and subsequent to these financial statements, the Company entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors for the issuance and sale of up to 14,285,714 shares of common stock of the Company and warrants to purchase up to an aggregate of 1,600,000 shares of Common Stock, representing up to $2,000,000 of proceeds, in one or more closings within 30 days of the Initial Closing Date (the “Transaction”). The warrants are exercisable at $0.25 per share for five years from the date of issuance and subject to anti-dilution protection as defined. As of May 10, 2016, the Company has received proceeds, net of costs, of $1,500,000.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States. Preparing financial statements requires our management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by our management’s application of accounting policies. We believe that understanding the basis and nature of the estimates and assumptions involved with the following aspects of our financial statements is critical to an understanding of our financial statements.

18 

Our critical accounting policies, as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, relate to capitalized legal patent costs, income taxes, goodwill, intangible assets, share-based payments, revenue recognition, and research and other accounting descriptions. There have been no material changes to our critical accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure.  Our management carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures.  Based on that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective as of March 31, 2016 due to omissions of disclosures in accordance with generally accepted accounting principles that have been substantially corrected as of May 18, 2015. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2014 as filed with the SEC on July 10, 2015 for a complete discussion relating to the foregoing evaluation of our controls and procedures.

Changes in Internal Control over Financial Reporting

There have been improvements in our internal controls over financial reporting that occurred after the year ended December 31, 2015. In the first quarter of 2016, we have engaged an outside financial expert to assist us with our more complex accounting issues and in the preparation of our quarterly and annual financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

In April 2015, two shareholder class action lawsuits were filed against us and our former officer Nathaniel Bradley and former officer Edward O’Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon.  The complaints seek, among other relief, compensatory damages and plaintiff’s counsel’s fees and experts’ fees. The Court has appointed a lead plaintiff and lead counsel. We have responded to the complaints and also filed a motion to dismiss. We believe that the lawsuits have no merit and intend to mount a vigorous defense. Given the current stage of the proceedings in this case, our management currently cannot assess the probability of losses, or reasonably estimate the range of losses, related to these matters. As of December 31, 2015, we have paid the deductible pursuant to the D&O insurance policy, in the amount of $100,000 regarding this matter.

We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

19 

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in Item 1.A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2015.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Sales of Unregistered Securities

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

20 

Item 6. Exhibits

Exhibit No.	Description
31.1*	Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

21 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 13 day of May 2016.

AUDIOEYE, INC.
By:	/s/ Dr. Carr Bettis
	Dr. Carr Bettis
	Principal Executive Officer
By:	/s/ Todd Bankofier
	Todd Bankofier
	Chief Executive Officer

22 

EX-31.1

Exhibit 31.1

CERTIFICATION UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dr. Carr Bettis, Principal Executive Officer of AudioEye, Inc. (the “Registrant”), certify that:

1.            I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2016 of AudioEye, Inc. (the “Quarterly Report”);

2.            Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

3.            Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

4.            The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

(b)            Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)            Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Annual Report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

(d)            Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.            The Registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

(b)            Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: May 13, 2016	By:	/s/ Dr. Carr Bettis
		Name:	Dr. Carr Bettis
		Title:	Principal Executive Officer and Principal Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing by AudioEye, Inc. (the “Registrant”) of its Quarterly Report on Form 10-Q for the period ended March 31, 2016 (the “Quarterly Report”) with the Securities and Exchange Commission, I, Dr. Carr Bettis, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i)            The Quarterly Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)           The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

A signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.

Date: May 13, 2016	By:	/s/ Dr. Carr Bettis
		Name:	Dr. Carr Bettis
		Title:	Principal Executive Officer and Principal Financial Officer

XML

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2016	May. 13, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Entity Registrant Name	AUDIOEYE INC
Entity Central Index Key	0001362190
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	AEYE
Entity Common Stock, Shares Outstanding		105,352,576

XML

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 1,080,490	$ 1,687,257
Accounts receivable, net	19,282	22,741
Marketable securities, held in related party	3,600	3,600
Non-marketable securities, held in related party	50,000	50,000
Prepaid expenses and other current assets	41,388	41,388
Total current assets	1,194,760	1,804,986
Intangible assets, net	2,738,385	2,840,856
Goodwill	700,528	700,528
Total assets	4,633,673	5,346,370
Current liabilities:
Accounts payable and accrued expenses	272,079	213,620
Notes and loans payable, current	24,000	24,000
Related party payables	135,710	153,474
Derivative liabilities	3,851,420	439,361
Deferred revenue	150,296	60,790
Total current liabilities	4,433,505	891,245
Long term liabilities:
Convertible notes and loans payable, net	1,963,640	1,923,499
Total liabilities	6,397,145	2,814,744
Stockholders' equity (deficit):
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, 175,000 issued and outstanding as of March 31, 2016 and December 31, 2015	2	2
Common stock, $0.00001 par value, 250,000,000 shares authorized, 81,717,154 shares issued and outstanding as of March 31, 2016 and December 31, 2015	817	817
Treasury stock	(623,000)	(623,000)
Additional paid in capital	27,609,016	27,393,238
Accumulated deficit	(28,750,307)	(24,239,431)
Total stockholders' equity (deficit)	(1,763,472)	2,531,626
Total liabilities and stockholders' equity (deficit)	$ 4,633,673	$ 5,346,370

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Preferred Stock, Par or Stated Value Per Share	$ 0.00001	$ 0.00001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	175,000	175,000
Preferred Stock, Shares Outstanding	175,000	175,000
Common Stock, Par or Stated Value Per Share	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Shares, Issued	81,717,154	81,717,154
Common Stock, Shares, Outstanding	81,717,154	81,717,154

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenues	$ 124,702	$ 101,038
Cost of revenue	294,808	462,131
Gross loss	(170,106)	(361,093)
Operating expenses:
Selling and marketing	123,366	366,368
Research and development	85,617	142,282
General and administrative	471,025	2,021,226
Amortization and depreciation	138,538	133,944
Total operating expenses	818,546	2,663,820
Operating loss	(988,652)	(3,024,913)
Other income (expense):
Unrealized loss on derivative liabilities	(3,412,059)	0
Interest income (expense), net	(110,165)	3,107
Total other income (expense)	(3,522,224)	3,107
Net loss	(4,510,876)	(3,021,806)
Preferred stock dividend	(21,875)	0
Net loss available to common stockholders	$ (4,532,751)	$ (3,021,806)
Net loss per common share-basic and diluted (in dollars per share)	$ (0.06)	$ (0.04)
Weighted average common shares outstanding-basic and diluted	81,717,154	78,736,420

XML

STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,510,876)	$ (3,021,806)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	138,538	133,944
Amortization of debt discounts	46,141	0
Option, warrant and PSU expense	215,778	559,793
Stock issued for services	0	314,663
Loss on change in derivative liabilities	3,412,059	0
Changes in operating assets and liabilities:
Accounts receivable	3,459	237,758
Other current assets	0	(48,713)
Accounts payable and accruals	58,459	(274,164)
Related party payables	(17,764)	(91,408)
Deferred revenue	89,506	(228,983)
Net cash (used in) operating activities	(564,700)	(2,418,916)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash (paid for) intellectual property	(36,067)	(29,650)
Net cash (used in) investing activities	(36,067)	(29,650)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock for cash	0	325,000
Collection of stock subscription receivable	0	1,175,000
Proceeds from exercise of options and warrants	0	43,942
Repayments of notes payable	(6,000)	(8,000)
Net cash (used in) provided by financing activities	(6,000)	1,535,942
Net decrease in cash	(606,767)	(912,624)
Cash-beginning of period	1,687,257	1,672,901
Cash-end of period	1,080,490	760,277
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	0	307
Income taxes paid	$ 0	$ 0

XML

ORGANIZATION AND BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION

The accompanying unaudited interim financial statements of AudioEye, Inc. and its wholly-owned subsidiary (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2016.

In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2015 as reported in the Company’s Annual Report on Form 10-K have been omitted.

Corporate Information and Background

AudioEye, Inc. was formed as a Delaware corporation on May 20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company’s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company’s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.

 

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation.

Revenue Recognition

Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract.

The Company had three major customers including their affiliates which generated approximately 72% (43%, 16% and 13%) of its revenue in the three months ended March 31, 2016.

Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue is earned.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.

Stock based compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.

Derivative Instrument Liability

The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At March 31, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.

On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to $25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In accordance with ASC 815, the outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At March 31, 2016 and December 31, 2015, the derivative liability was at $3,851,420 and $439,361, respectively. The change of $3,412,059 was driven by the increased value of the Company’s common stock in the period and recorded as the “Loss on change in derivative liability” in the Consolidated Statements of Operations. As the warrants are exercised or expire, the derivative liability will be reduced on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.

Fair Value Measurements

Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value. The notes are not yet convertible, but the notes with any accrued interest automatically convert on the event of an equity capital raise of at least $2.0 million.

The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years. At March 31, 2016, the price of the Company stock was 0.161, volatility was estimated to be 178.22%, the risk free rate of 1.21% and the remaining term ranged from 4.53 to 4.61 years. As of March 31, 2016, the fair value of the warrants was determined to be $3,851,420, resulting in an unrealized loss on the change in the fair value of this derivative liability of $3,412,059 for the three months ended March 31, 2016.

The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of March 31, 2016 and December 31, 2015:

			Fair Value
	Fair Value		Hierarchy
Assets
Marketable securities, March 31, 2016	$	3,600		Level 1
Marketable securities, December 31, 2015	$	3,600		Level 1
Liabilities
Derivative Liability , March 31, 2016	$	3,851,420		Level 3
Derivative Liability , December 31, 2015	$	439,361		Level 3

Recent Accounting Pronouncements

In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance.

There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

XML

MANAGEMENT LIQUIDITY PLANS

3 Months Ended

Mar. 31, 2016

Going Concern [Abstract]

Going Concern [Text Block]

NOTE 2: MANAGEMENT LIQUIDITY PLANS

The accompanying unaudited financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which contemplates the continuation of the Company as a going concern. As of March 31, 2016, the Company had a working capital deficit of $3,238,745 , principally due to the inclusion of non-cash derivative liability recorded in current liabilities. Excluding the derivative liability, the Company’s working capital would have been $612,675. In addition, the Company used actual net cash in operations of $564,700 during the three months ended March 31, 2016.

On April 18, 2016 (the “Initial Closing Date”) and subsequent to these financial statements, the Company entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors for the issuance and sale of up to 14,285,714 shares of common stock of the Company and warrants to purchase up to an aggregate of 1,600,000 shares of Common Stock, representing up to $2,000,000 of proceeds, in one or more closings within 30 days of the Initial Closing Date (the “Transaction”). The warrants are exercisable at $0.25 per share for five years from the date of issuance and subject to anti-dilution protection as defined. As of May 10, 2016, the Company has received proceeds, net of costs, of $1,500,000.

Management believes that the Company has sufficient funds to meet its operating funding requirements for at least the next twelve months. The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.

XML

RELATED PARTY TRANSACTIONS

3 Months Ended

Mar. 31, 2016

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

NOTE 3: RELATED PARTY TRANSACTIONS

The Company holds 60,000 shares in Peartrack Security Systems, formerly Ecologic Transportation, as of March 31, 2016 resulting from the conversion of a $60,000 accounts receivable balance in 2014 with a current fair value of the securities of $3,600. In 2014 the Company invested $50,000 in Cannonball Red in return for 97,500 shares held as of March 31, 2016. Both companies were affiliated with related parties who resigned from the Company during the quarter.

Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors

As of March 31, 2016 and December 31, 2015, the Company owed Dr. Bettis $49,742 and $72,944 in accrued salary, respectively. In addition, AudioEye sub-leases an office for the Company’s CEO Todd Bankofier from Verus Analytics, Inc, a company in which Dr. Bettis has a controlling interest in. The sub-lease amount is $500 per month totaling $1,500 in three months ended March 31, 2016.

Sean Bradley, President, Chief Technology Officer, and Secretary

As of March 31, 2016 and December 31, 2015 and 2014, the Company owed Sean Bradley $9,794 and $6,250 in accrued salary, respectively.

David Moradi, a Material Shareholder, on a fully diluted basis

As of March 31, 2016 and December 31, 2015 the Company owed David Moradi $70,000 in principal and $6,174 in accrued interest; and $70,000 in principal and $4,280 in accrued interest, respectively.

In summary, as of March 31, 2016 and December 31, 2015 the total balances of related party payables were $135,710 and $153,474, respectively.

XML

INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

NOTE 4: INTANGIBLE ASSETS

For the three months ended March 31, 2016 and 2015, the Company invested in Patents in the amounts of $36,067 and $29,650 respectively.

Prior to December 31, 2015, patents, technology and other intangibles with contractual terms were generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.

Software development costs are amortized over their estimated useful life of three years.

Prior to any impairment adjustment, intangible assets consisted of the following:

	March 31,		December 31,
	2016		2015
Patents	$	3,691,136	$	3,655,069
Capitalized software development		621,567		621,567
Accumulated amortization		(1,574,318)		(1,435,780)
Intangible assets, net	$	2,738,385	$	2,840,856

Amortization expense for patents totaled $92,779 and $90,736 for the three months ended March 31, 2016 and 2015, respectively. Amortization expense for software development totaled $45,759 and $43,125 for the three months ended March 31, 2016 and 2015, respectively.

Total amortization expense totaled $138,538 and $133,944 for the three months ended March 31, 2016 and 2015, respectively.

XML

NOTES PAYABLE

3 Months Ended

Mar. 31, 2016

Notes Payable [Abstract]

Debt Disclosure [Text Block]

NOTE 5: NOTES PAYABLE

As of March 31, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $1,963,640, and $24,000 and $1,923,499, respectively as shown in the table below.

Notes and loans payable	March 31, 2016		December 31, 2015
Short Term
Maryland TEDCO	$	24,000	$	24,000
Total	$	24,000	$	24,000
Long Term
Convertible Secured Note (net of unamortized discounts of $554,160 and $600,301, respectively)		1,945,840		1,899,699
Maryland TEDCO	$	17,800	$	23,800
Total	$	1,963,640	$	1,923,499

As of December 31, 2012, the Company had an outstanding loan to a third party in the amount of $74,900, which was originally issued during 2006 as part of an Investment Agreement. The loan was unsecured and bore interest at 25% per year for four years. The Company had accrued interest of $74,900, which was included in accounts payable and accrued expenses on the consolidated balance sheets.  The note was in default until October 24, 2011, at which time the Company entered into a Termination and Release Agreement (“Release”) with the third party.  The terms of the Release, among other things, terminated the Investment Agreement between the parties, and required the Company to issue a Promissory Note to the third-party in the combined amount of principal and accrued interest to date, for a total principal amount of $149,800.  The note is interest free, and is payable in monthly installments of $2,000 beginning November 1, 2011.  As of March 31, 2016 and December 31, 2015, the principal amount owing was $41,800 and $47,800, respectively, of which $24,000 and $24,000, respectively, has been recorded as the current portion of the note, and $17,800 and $23,800, respectively, as the long-term portion of the note. The Company has paid $6,000 for the three months ended March 31, 2016.

On October 9, 2015 (the “Initial Closing Date”), AudioEye, Inc. (the “Company”) entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) for the issuance and sale of convertible promissory notes in an aggregate principal amount of up to $3,750,000 (the “Notes”) and warrants (the “Warrants”) to purchase up to an aggregate of 37,500,000 shares of common stock of the Company (the “Common Stock”) (the “Transaction”). Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date. The maximum of $2,500,000 in aggregate principal was sold as of November 8, 2015. In addition, upon the election of any Investor within the three-year period immediately following the Initial Closing Date, any Investor may purchase an additional Note in the principal amount equal to 50% of the principal amount of the Notes purchased by such Investor at previous closings (the “Option Principal Amount”) and an additional Warrant with an aggregate exercise price equal to such Investor’s Option Principal Amount. The Notes mature three years from the date of issuance (the “Maturity Date”) and, until the Notes are repaid or converted into shares of the Company’s equity securities (“Equity Securities”), accrue payable-in-kind interest at the rate of 10% per annum.

If the Company sells Equity Securities in a single transaction or series of related transactions for cash of at least $2,000,000 (excluding the conversion of the Notes and excluding the shares of Common Stock to be issued upon exercise of the Warrants) on or before the Maturity Date (the “Equity Financing”), all of the unpaid principal on the Notes plus accrued interest shall be automatically converted at the closing of the Equity Financing into a number of shares of the same class or series of Equity Securities as are issued and sold by the Company in such Equity Financing (or a class or series of Equity Securities identical in all respects to and ranking pari passu with the class or series of Equity Securities issued and sold in such Equity Financing) as is determined by dividing (i) the principal and accrued and unpaid interest amount of the Notes by (ii) 60% of the price per share at which such Equity Securities are issued and sold in such Equity Financing. The Notes, if not converted, shall be due and payable in full on the Maturity Date.

The Notes contain customary events of default provisions. In connection with the issuance of the Notes, on October 9, 2015, the Company entered into a Security Agreement with the Investors (the “Security Agreement”) pursuant to which the Company granted a security interest in all of its assets to the Investors as collateral for the Company’s obligations under the Notes. The Warrants are exercisable at $0.10 per share and expire 60 months following the date of issuance. The Warrants are subject to anti-dilution protection, subject to certain customary exceptions.

During 2015, the Company issued notes under this offering totaling $2,500,000. The fair value of the warrants issued in connection with the notes was determined to be $627,293 and was recognized as a discount to the debt being amortized to interest expense over the life of the loans. During three months ended March 31, 2016, aggregate amortization of $46,141 was recognized against the discount.

XML

OPTIONS

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

NOTE 6: OPTIONS

As of March 31, 2016 and December 31, 2015, the Company has outstanding options to purchase 21,809,914 and 14,759,914 shares of common stock, respectively.

 

									Intrinsic
					Wtd Avg.				Value
	Number of		Wtd Avg.		Remaining				of Exercisable
	Options		Exercise Price		Term		Exercisable		Options
Outstanding at December 31, 2015		14,759,914	$	0.30		3.61		8,374,294	$	—
Granted		7,150,000		0.038		4.82				—
Forfeited		(100,000)		0.50						—
Outstanding at March 31, 2016		21,809,914	$	0.22		3.78		10,313,220	$	383,168

On January 15, 2016, the Company granted performance options to acquire shares of the Company’s common stock in aggregate of 6,500,000 to key board member and officers at an exercise price of $0.038 per share for five years. Vesting shall only occur if the closing share price of the Company’s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition). Of the granted options, 5,500,000 include performance conditions (as defined) with both conditions (market and performance) to be met before vesting. All determinations of whether performance goals have been achieved, the number of vested performance options earned by the grantee, and all other matters related to the award of performance options shall be made by the compensation committee of the Company’s board of directors in its sole discretion.

The estimated fair values of the options with performance and market conditions were determined using a Monte Carlo pricing model. Significant assumptions used in the valuation include expected term of 5 years, expected volatility of 162%, risk free interest rate of 1.46%, and expected dividend yield of 0%.

Nonperformance option grants during the three months ended March 31, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.50 years, expected volatility of 102%, risk free interest rate of 1.73%, and expected dividend yield of 0%.

For the three months ended March 31, 2016 and 2015, total stock compensation expense related to the options totaled $138,046 and $505,052, respectively.

XML

WARRANTS

3 Months Ended

Mar. 31, 2016

Warrants [Abstract]

Warrants [Text Block]

NOTE 7: WARRANTS

Below is a table summarizing the Company’s outstanding warrants as of March 31, 2016 and December 31, 2015:

									Intrinsic
					Wtd Avg.				Value
	Number of		Wtd Avg.		Remaining				of Exercisable
	Warrants		Exercise Price		Term		Exercisable		Warrants
Outstanding at December 31, 2015		42,526,609	$	0.22		4.15		41,047,920	$	1,167
Exercised		-
Granted		833,334		.06		3.07				-
Forfeited		-
Outstanding at March 31, 2016		43,359,943		0.21		3.87		43,141,193	$	1,666,625

The warrant grants during the three months ended March 31, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 2.5 years, expected volatility of 166.74% to 178.98%, risk free interest rate of 0.85% to 1.08%, and expected dividend yield of 0%.

 

For the three months ended March 31, 2016 and 2015, the Company has incurred warrant-based expense of $77,732 and $54,741, respectively. 

XML

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2016

Subsequent Events [Abstract]

Subsequent Events [Text Block]

NOTE 8: SUBSEQUENT EVENTS

Equity

Common stock

In April 2016, the Company issued an aggregate 83,336 shares of its common stock in payment for consulting services at a fair value of $14,292.

On April 18, 2016 (the “Initial Closing Date”) and subsequent to these financial statements, the Company entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors for the issuance and sale of up to 14,285,714 shares of common stock of the Company and warrants to purchase up to an aggregate of 1,600,000 shares of Common Stock, representing up to $2,000,000 of proceeds, in one or more closings within 30 days of the Initial Closing Date (the “Transaction”). The warrants are exercisable at $0.25 per share for five years from the date of issuance and subject to anti-dilution protection as defined. As of May 10, 2016, the Company has received proceeds, net of costs, of $1,500,000.

Registration rights

Under the purchase agreement, the Company has agreed to use its reasonable best efforts to prepare and file with the SEC registration statement within 60 days of the initial closing date, covering the resale by the investors of any common stock previously issued to the investors, and any common stock into which any convertible promissory notes previously issued to the investors are convertible and any common stock for which the warrants or any warrants previously issued to the investors are exercisable.

Amendments to Existing Agreements

In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Purchase Agreement Amendment”) and an Omnibus Amendment to Secured Promissory Notes (the “Note Amendment”), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the “Original Agreement”) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, “Anthion”) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of “qualified financing” under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing “blocker” provisions (“Special Warrants”) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar “blocker” provisions. 

On April 18, 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to the Note holders other than Anthion, and 18,353,311 warrants to acquire its common stock to Anthion in lieu of common stock. Collectively the common stock and warrants issued were in full settlement of $2,500,000 convertible notes (Note 5) and accrued interest of $74,658. The warrants issued to Anthion are exercisable at $0.0005 per share for five years from the date of issuance.

Employee options/warrants

On April 15, 2016, the Company issued 347,995 warrants to Dr. Carr Bettis as compensation for services rendered. The warrants are exercisable at $0.0179 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on April 1, 2016.

On April 15, 2016, the Company granted 49,715 options to Sean Bradley as compensation for services rendered. The options are exercisable at $0.0179 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on April 1, 2016.

XML

ORGANIZATION AND BASIS OF PRESENTATION (Policies)

3 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Reclassification, Policy [Policy Text Block]

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract.

The Company had three major customers including their affiliates which generated approximately 72% (43%, 16% and 13%) of its revenue in the three months ended March 31, 2016.

Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue is earned.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock based compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.

Derivatives, Policy [Policy Text Block]

Derivative Instrument Liability

The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At March 31, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.

On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to $25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In accordance with ASC 815, the outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At March 31, 2016 and December 31, 2015, the derivative liability was at $3,851,420 and $439,361, respectively. The change of $3,412,059 was driven by the increased value of the Company’s common stock in the period and recorded as the “Loss on change in derivative liability” in the Consolidated Statements of Operations. As the warrants are exercised or expire, the derivative liability will be reduced on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value Measurements

Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value. The notes are not yet convertible, but the notes with any accrued interest automatically convert on the event of an equity capital raise of at least $2.0 million.

The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the statement of operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years. At March 31, 2016, the price of the Company stock was 0.161, volatility was estimated to be 178.22%, the risk free rate of 1.21% and the remaining term ranged from 4.53 to 4.61 years. As of March 31, 2016, the fair value of the warrants was determined to be $3,851,420, resulting in an unrealized loss on the change in the fair value of this derivative liability of $3,412,059 for the three months ended March 31, 2016.

The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of March 31, 2016 and December 31, 2015:

			Fair Value
	Fair Value		Hierarchy
Assets
Marketable securities, March 31, 2016	$	3,600	Level 1
Marketable securities, December 31, 2015	$	3,600	Level 1
Liabilities
Derivative Liability , March 31, 2016	$	3,851,420	Level 3
Derivative Liability , December 31, 2015	$	439,361	Level 3

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance.

There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

XML

ORGANIZATION AND BASIS OF PRESENTATION (Tables)

3 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of March 31, 2016 and December 31, 2015:

			Fair Value
	Fair Value		Hierarchy
Assets
Marketable securities, March 31, 2016	$	3,600		Level 1
Marketable securities, December 31, 2015	$	3,600		Level 1
Liabilities
Derivative Liability , March 31, 2016	$	3,851,420		Level 3
Derivative Liability , December 31, 2015	$	439,361		Level 3

XML

INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Prior to any impairment adjustment, intangible assets consisted of the following:

	March 31,		December 31,
	2016		2015
Patents	$	3,691,136	$	3,655,069
Capitalized software development		621,567		621,567
Accumulated amortization		(1,574,318)		(1,435,780)
Intangible assets, net	$	2,738,385	$	2,840,856

XML

NOTES PAYABLE (Tables)

3 Months Ended

Mar. 31, 2016

Notes Payable [Abstract]

Schedule of Debt [Table Text Block]

As of March 31, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $1,963,640, and $24,000 and $1,923,499, respectively as shown in the table below.

Notes and loans payable	March 31, 2016		December 31, 2015
Short Term
Maryland TEDCO	$	24,000	$	24,000
Total	$	24,000	$	24,000
Long Term
Convertible Secured Note (net of unamortized discounts of $554,160 and $600,301, respectively)		1,945,840		1,899,699
Maryland TEDCO	$	17,800	$	23,800
Total	$	1,963,640	$	1,923,499

XML

OPTIONS (Tables)

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

As of March 31, 2016 and December 31, 2015, the Company has outstanding options to purchase 21,809,914 and 14,759,914 shares of common stock, respectively.

 

									Intrinsic
					Wtd Avg.				Value
	Number of		Wtd Avg.		Remaining				of Exercisable
	Options		Exercise Price		Term		Exercisable		Options
Outstanding at December 31, 2015		14,759,914	$	0.30		3.61		8,374,294	$	—
Granted		7,150,000		0.038		4.82				—
Forfeited		(100,000)		0.50						—
Outstanding at March 31, 2016		21,809,914	$	0.22		3.78		10,313,220	$	383,168

XML

WARRANTS (Tables)

3 Months Ended

Mar. 31, 2016

Warrants [Abstract]

Schedule of Other Share-based Compensation, Activity [Table Text Block]

Below is a table summarizing the Company’s outstanding warrants as of March 31, 2016 and December 31, 2015:

									Intrinsic
					Wtd Avg.				Value
	Number of		Wtd Avg.		Remaining				of Exercisable
	Warrants		Exercise Price		Term		Exercisable		Warrants
Outstanding at December 31, 2015		42,526,609	$	0.22		4.15		41,047,920	$	1,167
Exercised		-
Granted		833,334		.06		3.07				-
Forfeited		-
Outstanding at March 31, 2016		43,359,943		0.21		3.87		43,141,193	$	1,666,625

XML

ORGANIZATION AND BASIS OF PRESENTATION (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in related party	$ 3,600	$ 3,600	$ 3,600
Derivative Liability, Fair Value, Gross Liability		627,293
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in related party	3,600	3,600
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Fair Value, Gross Liability	$ 3,851,420	$ 439,361

XML

ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) - USD ($)		2 Months Ended	3 Months Ended
	Oct. 09, 2015	Nov. 30, 2015	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Nov. 09, 2015
Summary Of Significant Accounting Policies [Line Items]
Common Stock Issuance Price Per Share		$ 0.10
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.10	$ 0.10
Convertible Notes Payable		$ 2,000,000	$ 1,945,840		$ 1,899,699
Share Price			$ 0.161
Fair Value Assumptions, Risk Free Interest Rate			1.21%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			5 years
Fair Value Adjustment of Warrants			$ 3,851,420
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Change in Unrealized Gain (Loss)			3,412,059
Derivative Liability, Current			3,851,420		$ 439,361
Unrealized Gain (Loss) on Derivatives			$ (3,412,059)	$ 0
Class Of Warrant Or Right Exercisable Number	25,000,000
Debt Instrument, Face Amount	$ 2,500,000					$ 2,500,000
Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	5 years
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Share Price			$ 0.031
Fair Value Assumptions, Weighted Average Volatility Rate			102.00%
Fair Value Assumptions, Risk Free Interest Rate			1.14%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			4 years 6 months 11 days
Minimum [Member] | Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			1 year 6 months
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Share Price			$ 0.058
Fair Value Assumptions, Weighted Average Volatility Rate			178.22%
Fair Value Assumptions, Risk Free Interest Rate			1.75%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			4 years 7 months 10 days
Maximum [Member] | Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			2 years 6 months
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage			72.00%
Customer One [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage			43.00%
Customer Two [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage			16.00%
Customer Three [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage			13.00%

XML

MANAGEMENT LIQUIDITY PLANS (Details Textual) - USD ($)		1 Months Ended	3 Months Ended
	May. 10, 2016	Apr. 18, 2016	Mar. 31, 2016	Mar. 31, 2015	Nov. 30, 2015	Oct. 09, 2015
Going Concern And Management Liquidity Plans [Line Items]
Working Capital Amount			$ 3,238,745
Company used net cash in operations			(564,700)	$ (2,418,916)
Proceeds from Issuance of Common Stock			0	$ 325,000
Working Capital			$ 612,675
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.10	$ 0.10
Subsequent Event [Member]
Going Concern And Management Liquidity Plans [Line Items]
Stock Issued During Period, Shares, New Issues		14,285,714
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		1,600,000
Proceeds from Issuance of Common Stock	$ 1,500,000
Subsequent Event [Member] | Common Stock And Warrant Purchase [Member]
Going Concern And Management Liquidity Plans [Line Items]
Proceeds from Issuance of Common Stock		$ 2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.25
Warrant Expiration Term		5 years

XML

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Related Party Transaction [Line Items]
Cost method investment	$ 50,000	$ 50,000
Related party payables	135,710	153,474
Operating Leases, Rent Expense, Net, Total	1,500
Marketable Securities, Current, Total	3,600	3,600	$ 3,600
Executive Officer [Member]
Related Party Transaction [Line Items]
Due to Related Parties	49,742	72,944
Nathaniel Bradley
Related Party Transaction [Line Items]
Operating Leases, Rent Expense, Net, Total	$ 500
Peartrack Security Systems
Related Party Transaction [Line Items]
Shares owned	60,000
Ecologic Transportation
Related Party Transaction [Line Items]
Conversion of accounts receivable			60,000
Cannonball Red
Related Party Transaction [Line Items]
Cost method investment			$ 50,000
Shares owned	97,500
Sean Bradley
Related Party Transaction [Line Items]
Due to Related Parties	$ 9,794	6,250
David Moradi
Related Party Transaction [Line Items]
Due to Related Parties	70,000	70,000
Interest Receivable	$ 6,174	$ 4,280

XML

INTANGIBLE ASSETS (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Intangible Assets
Accumulated amortization	$ (1,574,318)	$ (1,435,780)
Intangible Assets, Net	2,738,385	2,840,856
Patents
Intangible Assets
Finite-Lived Intangible Assets, Gross	3,691,136	3,655,069
Capitalized software development
Intangible Assets
Finite-Lived Intangible Assets, Gross	$ 621,567	$ 621,567

XML

INTANGIBLE ASSETS (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 138,538	$ 133,944
Software Development Costs
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	45,759	43,125
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	92,779	90,736
Finite-lived Intangible Assets Acquired	$ 36,067	$ 29,650

XML

NOTES PAYABLE (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015	Nov. 30, 2015
Notes and loans payable
Short Term	$ 24,000	$ 24,000
Long Term	1,963,640	1,923,499
Convertible Secured Note (net of unamortized discounts of $554,160 and $600,301, respectively)	1,945,840	1,899,699	$ 2,000,000
Maryland TEDCO Note
Notes and loans payable
Short Term	24,000	24,000
Long Term	$ 17,800	$ 23,800

XML

NOTES PAYABLE (Details Textual) - USD ($)		1 Months Ended	3 Months Ended		12 Months Ended
	Oct. 09, 2015	Oct. 24, 2011	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Nov. 30, 2015	Nov. 09, 2015	Dec. 31, 2012
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 2,500,000						$ 2,500,000
Notes and Loans Payable, Current, Total			$ 24,000		$ 24,000
Long-term Debt, Total			1,963,640		1,923,499
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.10					$ 0.10
Notes and Warrants Exercisable Description	Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date.
Proceeds from Notes Payable					2,500,000
Derivative Liability, Fair Value, Gross Liability					627,293
Amortization of Debt Discount (Premium)			46,141	$ 0
Debt Instrument, Unamortized Discount (Premium), Net, Total			554,160		600,301
Note and Warrant Purchase Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount							$ 2,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	37,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	10.00%
Loans Payable
Debt Instrument [Line Items]
Long-term Debt, Gross								$ 74,900
Debt Instrument, Interest Rate, Stated Percentage								25.00%
Interest Payable, Current								$ 74,900
Maryland TEDCO Note
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment, Total		$ 2,000
Long-term Debt, Gross			41,800		47,800
Debt Instrument, Face Amount		$ 149,800
Notes and Loans Payable, Current, Total			24,000		24,000
Long-term Debt, Total			17,800		$ 23,800
Repayments of Long-term Debt, Total			$ 6,000
Notes
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 3,750,000
Debt Conversion Total Issued And Outstanding Common Shares Percent	60.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.10
Fair Value Assumptions, Expected Term	5 years
Proceeds from Sale of Available-for-sale Securities, Equity	$ 2,000,000

XML

OPTIONS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures
Granted Weighted Average Remaining Term	3 years 25 days
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding
Outstanding at beginning of the period (in shares)	14,759,914	14,759,914
Granted (in shares)	7,150,000
Forfeited (in shares)	(100,000)
Outstanding at the end of the period (in shares)	21,809,914	14,759,914
Exercisable (in shares)	10,313,220	8,374,294
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding at beginning of the period (in dollars per share)	$ 0.22	$ 0.30
Granted (in dollars per share)	0.038
Forfeited (in dollars per share)	$ 0.50
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures
Outstanding, Weighted Average Remaining Term	3 years 9 months 11 days	3 years 7 months 10 days
Granted Weighted Average Remaining Term	4 years 9 months 25 days
Share Based Compensation Arrangement by Share Based Payment Award Options, Intrinsic Value
Outstanding at beginning of the period, Intrinsic Value (in dollars)		$ 0
Granted, Intrinsic Value of Exercisable Options	$ 0
Forfeited, Intrinsic Value of Exercisable Options	$ 0
Outstanding at end of the period, Intrinsic Value (in dollars)	$ 383,168

XML

OPTIONS (Details Textual) - USD ($)			3 Months Ended
	Jan. 15, 2016	Dec. 22, 2015	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights		Vesting shall only occur if the closing share price of the Company’s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition).
Options
Granted (in shares)			7,150,000
Granted (in dollars per share)			$ 0.038
Share based compensation expense			$ 138,046	$ 505,052
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance			21,809,914		14,759,914	14,759,914
Performance Options [Member]
Granted (in shares)	6,500,000
Granted (in dollars per share)	$ 0.038
Expected term		5 years
Expected volatility (as a percent)		162.00%
Risk-free interest rate (as a percent)		1.46%
Expected dividend yield (as a percent)		0.00%
Performance Options [Member] | Performance and Market Conditions [Member]
Granted (in shares)	5,500,000
Non Performance Options [Member]
Expected term			1 year 6 months
Expected volatility (as a percent)			102.00%
Risk-free interest rate (as a percent)			1.73%
Expected dividend yield (as a percent)			0.00%

XML

WARRANTS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Number of warrants
Number of shares, beginning	42,526,609
Number of shares, exercised	0
Number of shares, granted	833,334
Number of shares, Forfeited	0
Number of shares, ending	43,359,943	42,526,609
Weighted average exercise price
Weighted average exercise price, beginning (in dollars per share)	$ 0.22
Weighted average exercise price, granted (in dollars per share) | $ / shares	0.06
Weighted average exercise price, ending (in dollars per share)	$ 0.21	$ 0.22
Weighted Average Remaining Term
Wtd Avg. Remaining Term	3 years 10 months 13 days	4 years 1 month 24 days
Wtd Avg. Remaining Term, granted	3 years 25 days
Exercisable
Exercisable (in shares)	43,141,193	41,047,920
Intrinsic Value
Outstanding at beginning of the period	$ 1,167
Intrinsic Value, granted		$ 0
Outstanding at ending of the period	$ 1,666,625	$ 1,167

XML

WARRANTS (Details Textual) - Warrants - USD ($)		3 Months Ended
	Oct. 09, 2015	Mar. 31, 2016	Dec. 31, 2015
Number of warrants
Expected term	5 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum		166.74%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum		178.98%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum		0.85%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum		1.08%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%
Deferred Compensation Liability, Current and Noncurrent		$ 77,732	$ 54,741
Minimum
Number of warrants
Expected term		1 year 6 months
Maximum
Number of warrants
Expected term		2 years 6 months

XML

SUBSEQUENT EVENTS (Details Textual) - USD ($)		1 Months Ended			3 Months Ended
	May. 10, 2016	Apr. 30, 2016	Apr. 18, 2016	Apr. 15, 2016	Mar. 31, 2016	Mar. 31, 2015	Nov. 30, 2015	Oct. 09, 2015
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.10	$ 0.10
Proceeds from Issuance of Common Stock					$ 0	$ 325,000
Subsequent Event
Subsequent Event [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			1,600,000
Common stock issued for services		83,336
Stock Issued During Period, Value, Issued for Services		$ 14,292
Stock Issued During Period, Shares, New Issues			14,285,714
Debt Conversion, Description			(a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of qualified financing under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing blocker provisions (Special Warrants) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar blocker provisions.
Proceeds from Issuance of Common Stock	$ 1,500,000
Subsequent Event | Common stock and Warrant purchase agreement [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			1,600,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.25
Stock Issued During Period, Shares, New Issues			14,285,714
Warrants Expiration Term			5 years
Proceeds from Issuance of Common Stock			$ 2,000,000
Subsequent Event | Amendments to Existing Agreements [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.0005
Stock Issued During Period, Shares, New Issues			12,834,800
Warrants Issued During Period, Shares			18,353,311
Warrants Expiration Term			5 years
Debt Conversion, Converted Instrument, Amount			$ 2,500,000
Interest Payable, Current			$ 74,658
Subsequent Event | Stock Compensation Plan [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				49,715
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.0179
Warrants Issued During Period, Shares				347,995
Warrants Expiration Term				3 years
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 0.0179
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term				3 years